[1] Fan J. Epidemiology of alcoholic and nonalcoholic fatty liver disease in china. J Gastroenterol Hepatol,2013,28: 11-17.
[2] Takuma Y.Helicobacter pylori infection and liver diseases.Gan To Kagaku Ryoho,2011,38: 362-364.
[3] Polyzossa, Kountouras J, Papatheodorou A, et al. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism,2013,62: 121-126.
[4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南. 肝脏, 2006, 11: 68-70.
[5] Polyzos SA, Kountouras J,Zavos C, et al. The association between Helicobacter pylori infection and insulin resistance:a systematic review.Helicobacter,2011,16: 79-88.
[6] Polyzos SA, Nikolopouios P, Stogianni A, et al. Effect of Helicobacter pylori eradication on hapaticsteatosis,NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis:a MR imaging-based pilot open-label study.Arq Gastoentero,2014,51: 261-268.
[7] Tonkic A, Tonkic M, Lehours P, et al. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter, 2012: 1-8.
[8] Dogan Z, Filik L, Ergul B, et al. Association between Helicobacter pylori and liver-to-spleen ratio:a randomized-controlled single-blind study. Eur J Gastroenterol Hepatol,2013,25: 107-110.
[9] 董九龙,徐新娟. 根除幽门螺杆菌对非酒精性脂肪肝病伴幽门螺杆菌感染治疗的影响,2016,44: 198-201. |
